[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AR018085A1 - Molecula polinucleotidica aislada; vector recombinante, celula hospedadora, producto genico avec, procedimiento para producirlo, procedimiento paraproducir un producto genico homologo, vector de reemplazo genico, vector recombinante, celula hospedadora streptomyces, procedimiento para identificarmut - Google Patents

Molecula polinucleotidica aislada; vector recombinante, celula hospedadora, producto genico avec, procedimiento para producirlo, procedimiento paraproducir un producto genico homologo, vector de reemplazo genico, vector recombinante, celula hospedadora streptomyces, procedimiento para identificarmut

Info

Publication number
AR018085A1
AR018085A1 ARP990100571A ARP990100571A AR018085A1 AR 018085 A1 AR018085 A1 AR 018085A1 AR P990100571 A ARP990100571 A AR P990100571A AR P990100571 A ARP990100571 A AR P990100571A AR 018085 A1 AR018085 A1 AR 018085A1
Authority
AR
Argentina
Prior art keywords
procedure
vector
produce
genetic
recombining
Prior art date
Application number
ARP990100571A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR018085A1 publication Critical patent/AR018085A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

La presente se refiere a moléculas polinucleotídicas que comprenden secuencias de nucleotidos que codifican un producto génico AveC, moléculaspolinucleotídicas que pueden usarse para alterar la relacion o cantidad de avermectinas de clases 2:1produc idas en cultivos de fermentacion de S. avermitilis.La presente se refiere además a vectores, células hospedadoras y cepas mutantes de S. avermitilis en las que el gen aveC se ha inactivado o mutado para cambiarla relacion o cantidad deavermectinas d e clases 2:1 producidas. También se refiere a procedimientos para identificar mutaciones de la ORF de aveC,procedimiento para obtener nuevas cepas S. avermitilis, procedimiento para producir avermectinas y composiciones de estas.
ARP990100571A 1998-02-13 1999-02-11 Molecula polinucleotidica aislada; vector recombinante, celula hospedadora, producto genico avec, procedimiento para producirlo, procedimiento paraproducir un producto genico homologo, vector de reemplazo genico, vector recombinante, celula hospedadora streptomyces, procedimiento para identificarmut AR018085A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7463698P 1998-02-13 1998-02-13

Publications (1)

Publication Number Publication Date
AR018085A1 true AR018085A1 (es) 2001-10-31

Family

ID=22120706

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990100571A AR018085A1 (es) 1998-02-13 1999-02-11 Molecula polinucleotidica aislada; vector recombinante, celula hospedadora, producto genico avec, procedimiento para producirlo, procedimiento paraproducir un producto genico homologo, vector de reemplazo genico, vector recombinante, celula hospedadora streptomyces, procedimiento para identificarmut

Country Status (32)

Country Link
EP (1) EP1053335A1 (es)
JP (2) JP2002503473A (es)
KR (3) KR20040053390A (es)
CN (2) CN1297485A (es)
AP (1) AP9901463A0 (es)
AR (1) AR018085A1 (es)
AU (1) AU752343C (es)
BG (1) BG64911B1 (es)
BR (1) BR9907893A (es)
CA (2) CA2320031A1 (es)
CO (1) CO5070698A1 (es)
DZ (1) DZ2720A1 (es)
EA (1) EA003905B1 (es)
GT (1) GT199900014A (es)
HN (1) HN1999000008A (es)
HR (1) HRP20000539A2 (es)
HU (1) HUP0100784A3 (es)
IL (2) IL137610A0 (es)
IS (1) IS5567A (es)
MA (1) MA24760A1 (es)
NO (1) NO20004044L (es)
NZ (2) NZ518657A (es)
OA (1) OA11449A (es)
PA (1) PA8467601A1 (es)
PE (1) PE20000352A1 (es)
PL (1) PL194270B1 (es)
SK (1) SK11722000A3 (es)
TN (1) TNSN99017A1 (es)
TW (1) TW585910B (es)
WO (1) WO1999041389A1 (es)
YU (1) YU50900A (es)
ZA (1) ZA991138B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040053390A (ko) * 1998-02-13 2004-06-23 화이자 프로덕츠 인코포레이티드 아베르멕틴의 비2:비1의 비를 제어할 수 있는 스트렙토마이세스 아베르미틸리스 유전자
US6248579B1 (en) * 1998-02-13 2001-06-19 Pfizer Inc Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
IL147563A0 (en) * 1999-08-12 2002-08-14 Pfizer Prod Inc Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
US7630836B2 (en) * 2001-05-30 2009-12-08 The Kitasato Institute Polynucleotides
ES2373629T3 (es) * 2002-02-12 2012-02-07 Pfizer Products Inc. Gen de streptomyces avemitilis que dirige la proporción de avermectinas b2:b1.
CN107338210B (zh) * 2017-09-05 2021-08-17 天津科技大学 一种阿维链霉菌合成培养基及其发酵液的制备方法
CN111269296B (zh) * 2020-03-06 2021-11-05 山东大学 一种nLsA蛋白及其结构基因和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4429042A (en) * 1978-09-08 1984-01-31 Merck & Co., Inc. Strain of Streptomyces for producing antiparasitic compounds
IN167980B (es) * 1987-01-23 1991-01-19 Pfizer
ATE89604T1 (de) * 1987-10-23 1993-06-15 Pfizer Verfahren zur herstellung von aglykonen von avermectin und sie enthaltende kulturen.
JPH0747171B2 (ja) * 1988-09-20 1995-05-24 株式会社東芝 圧延機の設定方法および装置
DE69023036T2 (de) * 1989-03-31 1996-06-13 Merck & Co Inc Klonierung von Streptomyces avermitilis Genen zur Biosynthese von Avermectin und Verfahren zu ihrer Verwendung.
US5252474A (en) * 1989-03-31 1993-10-12 Merck & Co., Inc. Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use
JP2888586B2 (ja) * 1990-03-05 1999-05-10 社団法人北里研究所 エバーメクチンの特定成分を選択生産するための微生物およびその選択的製造法
FI942725A (fi) * 1993-12-16 1995-06-17 Pfizer Haaraketjuista alfaketohappodenydrogenaasikompleksia koodaavia geenejä Streptomyces avermitiliksesta
KR20040053390A (ko) * 1998-02-13 2004-06-23 화이자 프로덕츠 인코포레이티드 아베르멕틴의 비2:비1의 비를 제어할 수 있는 스트렙토마이세스 아베르미틸리스 유전자

Also Published As

Publication number Publication date
JP2002503473A (ja) 2002-02-05
NZ518657A (en) 2003-10-31
IL183596A0 (es) 2007-09-20
CN1521180A (zh) 2004-08-18
YU50900A (sh) 2004-03-12
IL137610A0 (en) 2001-07-24
ZA991138B (en) 2000-08-14
AU752343C (en) 2005-11-03
BG104759A (en) 2001-04-30
CA2320031A1 (en) 1999-08-19
HRP20000539A2 (en) 2001-04-30
AP9901463A0 (en) 1999-03-31
NO20004044L (no) 2000-10-11
HUP0100784A2 (hu) 2001-06-28
PL194270B1 (pl) 2007-05-31
CN1297485A (zh) 2001-05-30
EA003905B1 (ru) 2003-10-30
KR20040053390A (ko) 2004-06-23
BG64911B1 (bg) 2006-08-31
NO20004044D0 (no) 2000-08-11
BR9907893A (pt) 2000-11-14
EP1053335A1 (en) 2000-11-22
CA2521289A1 (en) 1999-08-19
KR20040099389A (ko) 2004-11-26
PA8467601A1 (es) 2000-09-29
KR20010052166A (ko) 2001-06-25
JP4011036B2 (ja) 2007-11-21
WO1999041389A1 (en) 1999-08-19
AU752343B2 (en) 2002-09-19
AU1887899A (en) 1999-08-30
MA24760A1 (fr) 1999-10-01
KR100499214B1 (ko) 2005-07-07
GT199900014A (es) 2000-07-25
JP2004283174A (ja) 2004-10-14
CO5070698A1 (es) 2001-08-28
PE20000352A1 (es) 2000-05-16
SK11722000A3 (sk) 2001-04-09
OA11449A (en) 2003-12-03
PL342468A1 (en) 2001-06-04
HUP0100784A3 (en) 2004-10-28
HN1999000008A (es) 1999-10-29
TNSN99017A1 (fr) 2005-11-10
NZ505676A (en) 2003-02-28
DZ2720A1 (fr) 2003-09-01
EA200000758A1 (ru) 2001-04-23
IS5567A (is) 2000-07-20
TW585910B (en) 2004-05-01

Similar Documents

Publication Publication Date Title
Sanchez et al. Paenibacillus barcinonensis sp. nov., a xylanase-producing bacterium isolated from a rice field in the Ebro River delta
HUP0100045A2 (hu) Eljárás aminosav-termelő baktériumtörzsek előállítására és az aminosavaknak az előállított aminosav-termelő baktériumtörzsekből fermentálással történő előállítására
Asem et al. Desertimonas flava gen. nov., sp. nov. isolated from a desert soil, and proposal of Ilumatobacteraceae fam. nov.
Vaz-Moreira et al. Bacillus purgationiresistans sp. nov., isolated from a drinking-water treatment plant
Shin et al. Cochleicola gelatinilyticus gen. nov., sp. nov., isolated from a marine gastropod, Reichia luteostoma
AR018085A1 (es) Molecula polinucleotidica aislada; vector recombinante, celula hospedadora, producto genico avec, procedimiento para producirlo, procedimiento paraproducir un producto genico homologo, vector de reemplazo genico, vector recombinante, celula hospedadora streptomyces, procedimiento para identificarmut
UY26287A1 (es) Gen de streptomyces avermitilis que que dirige la relación de avermectinas b2:b1
CY1105778T1 (el) Γονιδιο του streptomyces avermitilis που κατευθυνει την αναλογια των αβepμεκτινων β2:β1
CY1112491T1 (el) Γονιδιο streptomyces avermitilis που ελεγχει την αναλογια αβερμεκτινων β2:β1
Hwang et al. Flectobacillus lacus sp. nov., isolated from a highly eutrophic pond in Korea
Kämpfer et al. Ornithinimicrobium murale sp. nov., isolated from an indoor wall colonized by moulds
BR0110128A (pt) Mutante de bactéria láctica superprodutora de exopolissacarìdeos, utilização do mesmo e ácido nucleico codificando uma alfa-fosfoglucomutase
Sultanpuram et al. Cohaesibacter haloalkalitolerans sp. nov., isolated from a soda lake, and emended description of the genus Cohaesibacter
Han et al. Botryobacter ruber gen. nov., sp. nov., a novel member of the family Hymenobacteraceae
Lin et al. Humibacter aquilariae sp. nov., an actinobacterium isolated from an agarwood chip
Feng et al. Amylibacter lutimaris sp. nov., isolated from sea-tidal flat sediment
Koh et al. Characterization of Miniimonas sp. S16 isolated from activated sludge
Coahuila et al. Chapter Title Isolation and Screening of Halophilic Bacteria for Production of Hydrolytic Enzymes Copyright Year 2015 Copyright Holder Springer International Publishing Switzerland Author Family Name Delgado-García

Legal Events

Date Code Title Description
FB Suspension of granting procedure